Delivery Order SPE2DB20D9329-SPE2DB23FZM09
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE, with an ultimate completion date of October 19, 2023 and a ceiling value of $18,568.80. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,663.60, is for the delivery of XOLAIR 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,568.80 contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through August 19, 2024. The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a ceiling value of $18,568.80 and an ultimate completion date of November 22, 2024. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the supply of XOLAIR 150 MG/ML syringes. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a ceiling value of $11,605.50 and a period of performance through January 28, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $4,642.20 and has an ultimate completion date of December 6, 2023. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML, with a ceiling value of $1,813.12 and a period of performance through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $38,685, is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, valued at up to $499,999,999...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB23FZM09Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a ceiling value of $38,685.00, is for the delivery of XOLAIR 150 MG/ML syringes and is set to expire on October 12, 2023. The contract is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.7k | 9/20/23 |